Close

Danaher's (DHR) Acquisition of Cepheid is Credit-Negative Development - Moody's

Go back to Danaher's (DHR) Acquisition of Cepheid is Credit-Negative Development - Moody's

S&P Places Danaher's (DHR) Ratings on CreditWatch Negative Amid Move to Acquire Cepheid

September 6, 2016 2:35 PM EDT

S&P Global Ratings placed its ratings on Danaher Corp. (NYSE: DHR), including the 'A' corporate credit and 'A-1' commercial paper rating, on CreditWatch with negative implications, following its pending acquisition of Cepheid Inc. for $4 billion.

"The CreditWatch placement reflects our view that the timing of Danaher's proposed $4 billion debt-financed acquisition of Cepheid and the high acquisition multiple may manifest a shift toward a more aggressive financial policy than we previously expected resulting in leverage maintained above 2.5x," said S&P Global... More

Piper Jaffray Downgrades Cepheid (CPHD) to Neutral

September 6, 2016 9:13 AM EDT

Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from Overweight to Neutral.

For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.

Shares of Cepheid closed at $34.42 yesterday.

... More

Wall St. ends up on views Fed will hold off on rates

September 6, 2016 7:38 AM EDT

By Caroline Valetkevitch

(Reuters) - U.S. stocks rose slightly on Tuesday, nudging the Nasdaq to a record high close, as economic data bolstered views the Federal Reserve may decide against raising interest rates in the near term.

The S&P financial index , which tends to rise with expectations for higher rates, slipped 0.2 percent, while the S&P utilities index , which tends to benefit from a lower rate environment, rose 1.1 percent.

A weaker-than-expected reading on the U.S. services sector in August added to views the Fed... More

Cepheid (CPHD) volatility low into Danaher (DHR) acquiring for $53 per share

September 6, 2016 7:00 AM EDT

Cepheid (NASDAQ: CPHD) September call option implied volatility is at 37, October is at 43; compared to its 52-week range of 38 to 79 into Danaher (DHR) acquiring all of the outstanding shares of Cepheid for $53 per share in cash.

... More